大葉大學圖書館 |

Genotoxicity and carcinogenicity testing of pharmaceuticals[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.994071
書名/作者:	Genotoxicity and carcinogenicity testing of pharmaceuticals/ edited by Michael J. Graziano, David Jacobson-Kram.
其他作者:	Graziano, Michael J.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	x, 206 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Genetic toxicology.
標題:	Carcinogenicity testing.
標題:	Biomedicine.
標題:	Cancer Research.
標題:	Pharmaceutical Sciences/Technology.
ISBN:	9783319220840
ISBN:	9783319220833
內容註:	Introduction -- History and Current Regulatory Requirements -- Genotoxicity Testing of API and Impurities -- New Emerging Genotoxicity Tests -- Carcinogenicity Testing of Small Molecules -- Alternatives to the 2-Year Rodent Studies -- Addressing Positive Findings in Carcinogenicity Studies -- Investigating Tumor Signals in Clinical Trials -- Tumor Promoters -- Carcinogenicity Testing of Biologics -- In Silico Predictive Tests.
摘要、提要註:	This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.
電子資源:	http://dx.doi.org/10.1007/978-3-319-22084-0

Genotoxicity and carcinogenicity testing of pharmaceuticals[electronic resource] /
Genotoxicity and carcinogenicity testing of pharmaceuticals[electronic resource] /edited by Michael J. Graziano, David Jacobson-Kram. - Cham :Springer International Publishing :2015. - x, 206 p. :ill., digital ;24 cm.

Introduction -- History and Current Regulatory Requirements -- Genotoxicity Testing of API and Impurities -- New Emerging Genotoxicity Tests -- Carcinogenicity Testing of Small Molecules -- Alternatives to the 2-Year Rodent Studies -- Addressing Positive Findings in Carcinogenicity Studies -- Investigating Tumor Signals in Clinical Trials -- Tumor Promoters -- Carcinogenicity Testing of Biologics -- In Silico Predictive Tests.

This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.

ISBN: 9783319220840

Standard No.: 10.1007/978-3-319-22084-0doiSubjects--Topical Terms:

339094
Genetic toxicology.

LC Class. No.: RC268.65

Dewey Class. No.: 616.994071

Genotoxicity and carcinogenicity testing of pharmaceuticals[electronic resource] /
LDR:02466nam a2200313 a 4500 001 443692
003 DE-He213
005 20160411142414.0
006 m d
007 cr nn 008maaau
008 160715s2015 gw s 0 eng d
020 $a 9783319220840 $q (electronic bk.)
020 $a 9783319220833 $q (paper)
024 7 $a 10.1007/978-3-319-22084-0 $2 doi
035 $a 978-3-319-22084-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.65
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994071 $2 23
090 $a RC268.65 $b .G335 2015
245 0 0 $a Genotoxicity and carcinogenicity testing of pharmaceuticals $h [electronic resource] / $c edited by Michael J. Graziano, David Jacobson-Kram.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a x, 206 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- History and Current Regulatory Requirements -- Genotoxicity Testing of API and Impurities -- New Emerging Genotoxicity Tests -- Carcinogenicity Testing of Small Molecules -- Alternatives to the 2-Year Rodent Studies -- Addressing Positive Findings in Carcinogenicity Studies -- Investigating Tumor Signals in Clinical Trials -- Tumor Promoters -- Carcinogenicity Testing of Biologics -- In Silico Predictive Tests.
520 $a This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.
650 0 $a Genetic toxicology. $3 339094
650 0 $a Carcinogenicity testing. $3 344049
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Pharmaceutical Sciences/Technology. $3 464319
700 1 $a Graziano, Michael J. $3 634580
700 1 $a Jacobson-Kram, David. $3 634581
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-22084-0
950 $a Biomedical and Life Sciences (Springer-11642)